isabelobrien, Author at European Medical Journal - Page 7 of 29

stamp of approval

Eli Lilly’s tirzepatide wins FDA nod for sleep apnea

Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep disorder.

Tessera's sickle cell gene therapy wins Gates Foundation backing

Tessera Therapeutics has announced a partnership with the Bill & Melinda Gates Foundation, securing funding of up to $50m.

Orange lungs on yellow background

Respiratory infections cost UK businesses £44bn annually

A new report by the Office of Health Economics (OHE), commissioned by Pfizer, reveals that respiratory infections can be bad for business.

Hook, line and sinker: Catching the attention of HCPs

Attention is the new currency in pharma marketing. With HCPs overwhelmed by information, delivering engaging content is crucial to standing out.

Handshake on a green background

Lilly gains EU backing for drug to treat Crohn’s disease

The drug has received a nod from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

GSK drug shows promise in multiple myeloma

A trial has shown that belantamab mafodotin can reduce the risk of death by 42% in patients with relapsed or refractory multiple myeloma.

white house on blue background

Biden-Harris Administration expands access to sickle cell disease treatments

In a victory for people with sickle cell disease, the US government has announced a major step towards improving access to treatment.

The word spotlight on a blue background

Spotlight: November 2024

Catch up on all the biggest pharma news to hit the industry last month, with stories spanning the US election, new breakthroughs and more.

ABPI calls for MHRA reform to drive UK life sciences growth

As the MHRA begins a new chapter, the ABPI has published a report outlining the importance of regulatory excellence in the UK.

Donald Trump picks last role in health leadership team

President-elect Donald Trump has picked the final post in his health team, selecting Dr Jay Bhattacharya to be Director of the US National Institutes of Health.